Higher bleeding risk is tied to SSRIs, surgery study finds

05/21/2013

A study in JAMA Internal Medicine has found a link between the use of selective serotonin reuptake inhibitors, a common class of antidepressants, and a greater risk of surgery-related bleeding, transfusion, readmission and death. Scientists analyzed data on more than 530,000 operations at 375 hospitals. Researchers called for a prospective observational study on the effects of SSRIs in surgery.

View Full Article in:

Nurse.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN